This technique allowed us to export statistics of standardised uptake value (SUV) and lesion volume for each metastatic site: In an exemplar patient case with metastatic prostate cancer a reduction in mean SUV, median SUV and lesion volume was observed following treatment, in agreement with a concurrent reduction in serum PSA levels. Here, KLK3 is linked to metastatic prostate carcinoma.